Shuttle Pharmaceuticals (SHPH) announced that the reverse stock split will become effective on June 16, at 12:01 a.m., Eastern Time. The company’s common stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SHPH” and will begin trading on a split-adjusted basis when the market opens on June 16. At the effective time of the reverse stock split, every 25 shares of the company’s issued and outstanding common stock will be automatically reclassified and combined into 1 share of common stock. This will reduce the number of issued and outstanding shares of common stock from 26,210,037 shares to approximately 1,048,401 shares, without giving effect to rounding
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHPH:
- Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split
- Shuttle Pharmaceuticals appoints George Scorsis as chairman
- Shuttle Pharmaceuticals Announces Major Salary Reductions
- Shuttle Pharmaceuticals Announces Leadership Changes and Meeting Outcomes
- Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment